Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Silke M. Currie"'
Autor:
Karina Mildner, Leonhard Breitsprecher, Silke M. Currie, Rebekka I. Stegmeyer, Malte Stasch, Stefan Volkery, Olympia Ekaterini Psathaki, Dietmar Vestweber, Dagmar Zeuschner
Publikováno v:
Histochemistry and cell biology. 158(2)
The nanometer spatial resolution of electron microscopy imaging remains an advantage over light microscopy, but the restricted field of view that can be inspected and the inability to visualize dynamic cellular events are definitely drawbacks of stan
Autor:
Silke M. Currie, Rebekka I. Stegmeyer, Karina Mildner, Leonhard Breitsprecher, Dagmar Zeuschner, Olympia Ekaterini Psathaki, Kerstin Schäfer, Markus Wilkens, Stefan Volkery, Bernhard Nieswandt, Dietmar Vestweber
Publikováno v:
The Journal of investigative dermatology. 142(10)
Platelets preserve vascular integrity during immune complex‒mediated skin inflammation by preventing neutrophil-provoked hemorrhage. However, the single-cell dynamics of this hemostatic process have never been studied in real-time. To monitor the o
Autor:
Silke M Currie, Emily Gwyer Findlay, Brian J McHugh, Annie Mackellar, Tian Man, Derek Macmillan, Hongwei Wang, Paul M Fitch, Jürgen Schwarze, Donald J Davidson
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73659 (2013)
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions
Externí odkaz:
https://doaj.org/article/6bc4431fc09a4e508c8c07a5dfaab2b8
Autor:
Jürgen Schwarze, Emily Gwyer Findlay, Allan Paras, Agnieszka Jozwik, Amanda J. McFarlane, Christopher Chiu, Nick Colegrave, Donald J. Davidson, Paul M. Fitch, Silke M. Currie, Bettina Böttcher
Publikováno v:
The Journal of Immunology Author Choice
Currie, S M, Gwyer Findlay, E, McFarlane, A, Fitch, P, Boettcher, A, Colegrave, N, Paras, A, Jozwik, A, Chiu, C, Schwarze, J & Davidson, D J 2016, ' Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans. ', Journal of Immunology, vol. 196, no. 6, pp. 2699-2710 . https://doi.org/10.4049/jimmunol.1502478
Currie, S M, Gwyer Findlay, E, McFarlane, A, Fitch, P, Boettcher, A, Colegrave, N, Paras, A, Jozwik, A, Chiu, C, Schwarze, J & Davidson, D J 2016, ' Cathelicidins have direct antiviral activity against respiratory syncytial virus in vitro and protective function in vivo in mice and humans. ', Journal of Immunology, vol. 196, no. 6, pp. 2699-2710 . https://doi.org/10.4049/jimmunol.1502478
Respiratory syncytial virus (RSV) is a leading cause of respiratory tract infection in infants, causing significant morbidity and mortality. No vaccine or specific, effective treatment is currently available. A more complete understanding of the key
Publikováno v:
Barlow, P G, Gwyer Findlay, E, Currie, S M & Davidson, D J 2014, ' Antiviral potential of cathelicidins ', Future Microbiology, vol. 9, no. 1, pp. 55-73 . https://doi.org/10.2217/fmb.13.135
ABSTRACT: The global burden of morbidity and mortality arising from viral infections is high; however, the development of effective therapeutics has been slow. As our understanding of innate immunity has expanded over recent years, knowledge of natur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e56237cbe1e9fbc596d595f7425d83b9
https://hdl.handle.net/20.500.11820/dcdd3c66-949d-463d-9d6d-7dc708ba0e5d
https://hdl.handle.net/20.500.11820/dcdd3c66-949d-463d-9d6d-7dc708ba0e5d
Autor:
Donald J. Davidson, Emily Gwyer Findlay, Paul M. Fitch, Jürgen Schwarze, Hongwei Wang, Annie Mackellar, Tian Man, Brian J. McHugh, Derek Macmillan, Silke M. Currie
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e73659 (2013)
PLoS ONE
Currie, S M, Gwyer Findlay, E, McHugh, B J, Mackellar, A, Man, T, Macmillan, D, Wang, H, Fitch, P M, Schwarze, J & Davidson, D J 2013, ' The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus ', PLoS ONE, vol. 8, no. 8, e73659 . https://doi.org/10.1371/journal.pone.0073659
PLoS ONE
Currie, S M, Gwyer Findlay, E, McHugh, B J, Mackellar, A, Man, T, Macmillan, D, Wang, H, Fitch, P M, Schwarze, J & Davidson, D J 2013, ' The Human Cathelicidin LL-37 Has Antiviral Activity against Respiratory Syncytial Virus ', PLoS ONE, vol. 8, no. 8, e73659 . https://doi.org/10.1371/journal.pone.0073659
Respiratory syncytial virus is a leading cause of lower respiratory tract illness among infants, the elderly and immunocompromised individuals. Currently, there is no effective vaccine or disease modifying treatment available and novel interventions
Publikováno v:
BioDrugs
Gwyer Findlay, E, Currie, S M & Davidson, D J 2013, ' Cationic Host Defence Peptides : Potential as Antiviral Therapeutics ', BioDrugs, vol. 27, no. 5, pp. 479-493 . https://doi.org/10.1007/s40259-013-0039-0
Biodrugs
Gwyer Findlay, E, Currie, S M & Davidson, D J 2013, ' Cationic Host Defence Peptides : Potential as Antiviral Therapeutics ', BioDrugs, vol. 27, no. 5, pp. 479-493 . https://doi.org/10.1007/s40259-013-0039-0
Biodrugs
There is a pressing need to develop new antiviral treatments; of the 60 drugs currently available, half are aimed at HIV-1 and the remainder target only a further six viruses. This demand has led to the emergence of possible peptide therapies, with 1